# Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.

> **NCT06346301** · NA · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 36 (estimated)

## Conditions studied

- Obsessive-Compulsive Disorder
- Body Dysmorphic Disorders
- Anxiety Disorders

## Interventions

- **BEHAVIORAL:** Imagery rescripting

## Key facts

- **NCT ID:** NCT06346301
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-21
- **Primary completion:** 2026-01
- **Final completion:** 2027-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06346301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06346301, "Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06346301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*